Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases that is headquartered in Menlo park, California and was founded in 2014 by Aya Jakobovitis.
Funding
Venture
On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.
Series A
On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.
Acquisitions
Applied Immune Technologies
On January 27, 2016 Adicet Bio acquired the Israeli immunotherapy company Applied Immune Technologies.
Timeline
Series A funding round
On January 27, 2016 Adicet Bio completed their series A funding round with $51 million in funding from OrbiMed (lead investor), Pontifax, and Novartis Venture Fund.
Venture funding round
On August 26, 2015 Adicet Bio completed a venture capital round raising $14.6 million in funding from undisclosed investors.
Funding rounds
People
Further reading
Documentaries, videos and podcasts
Companies
References
Company attributes
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Seeking to explain science and technology through simple writing. - 2
Aime Anne Nisay
QA Engineer of web and mobile applications - 3
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 4
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 5
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME